
|Articles|May 15, 2002
FDA Briefs
FDA approves Refractec's CK nonlaser procedure for farsightedness
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























